After its recent merger with McKesson, Change Healthcare has become one of the nation’s leading healthcare technology companies. Change Healthcare has become a hub in the US healthcare system by enabling one of the highest volume of healthcare transactions in the country.
Having partnered with Change Healthcare Remedly is uniquely positioned to present its customers with powerful, effective solutions for their needs and challenges.
Through a partnership with Change Healthcare, Remedly gained access to virtually all private and government payers, thousands of medical and dental providers, pharmacies, and labs.
Through 360 Payments Remedly offers its customers merchant services seamlessly integrated with Remedly’s billing module. 360 Payments is a payments processor founded on the beliefs and core values of honesty and integrity. The credit card processing industry is very competitive and can be confusing. 360 Payments began its journey with the intent to change the fabric of the industry through exemplary customer support, community service, and exceptional employment opportunities that allow team members to earn a competitive and honest income.
Ellkay supports the data migration processes for Remedly’s customers who are transitioning from old, legacy systems to Remedly. Ellkay has many years of experience and strong relationships with the nation's leading laboratories to help Remedly provide its customers with a smooth onboarding experience.
Ellkay has performed numerous data transfers from various systems to Remedly, which include transferring patient demographic information, appointments, and other pertinent data. Remedly’s Customer Success team guides the whole process and helps provide incoming customers with peace of mind.
A 100+-year-old company owned by a research-focused foundation, Leo iLab doesn’t develop medical treatments but rather focuses on digital solutions that address the challenges patients face today.
Established by LEO Pharma, the iLab was built to drive radical innovation and enable bringing it to the market faster. The iLab’s mission is enabled by LEO Pharma’s unique ownership structure – owned by the LEO Foundation, with no shareholders, all profits are reinvested to help patients.
Remedly is proud to be part of the Stanford StartX community of Stanford University affiliated founders and companies. StartX was named the best start-up accelerator in the US in 2018. Recognizing that medical start-ups have industry-specific needs not addressed by the typical accelerator, StartX helps founders navigate the often complex needs of the medical industry such as wet/dry lab space, animal testing facilities, clean rooms and specialized instruction on med-tech intellectual property and the FDA approval process to medical companies.
StartX Med focuses on "Advancing breakthrough healthcare technologies by accelerating the development of Stanford's highest-potential medical entrepreneurs." They do so by focusing on people in order to develop a community and educate our founders in their efforts to transform healthcare. They support founders across the entire innovation life cycle in biotechnology, medical device, health IT, care delivery innovation, imaging and diagnostics.
StartX is an independent entity that has partnered with both Stanford University & Stanford Health Care. It has operated as a launching point for companies founded by students and alumni. Over the years it has aggressively expanded the scope of its program and the number of founders that count themselves as part of its community.
At its start, the accelerator primarily helped students and first-time founders in the earliest stages of company formation and product development. But as time has gone on, StartX has gradually added support for serial entrepreneurs and growth-stage companies.
While StartX doesn’t take equity in the companies that participate, the accelerator has partnered with Stanford to invest in its startups. The Stanford-StartX Fund is an investment vehicle that is entirely opt-in for StartX startups to take advantage of, as it offers to invest in up to 10 percent of a company’s financing round as long as they meet a set of objective criteria.
Founded in 1996, FCA Venture Partners has a long history of investing in successful healthcare entrepreneurs. Located in Brentwood, Tennessee, FCA is passionate about building sustainable businesses and providing strategic value to their portfolio companies.
FCA invests $3-6M in fast growing healthcare companies making processes in the industry faster, better, and cheaper while improving the quality of care and improving the patient experience.
With its location in Nashville, roots with Clayton Associates and the McWhorter Family, and deep involvement in the growth of the U.S. healthcare community, FCA Venture Partners is poised to take advantage of disruptive opportunities that help move healthcare forward.
GSR Ventures is a venture capital firm located in Palo Alto, California focused on early-stage technology companies.They back entrepreneurs with global ambitions – entrepreneurs building large, disruptive businesses that have the potential to dominate multi-billion dollar markets. They were the first institutional investors in DiDi Chuxing, ele.me, Inke, ofo, Qunar, Shanghai DZH and Xiaohongshu.
GSR Ventures currently manages over $2 billion in investment assets.